Label: YAKKONGMO TREATMENT- pyrithione zinc, dexpanthenol, niacinamide, biotin liquid
- NDC Code(s): 73540-003-01
- Packager: BOBSNU CO., LTD.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Updated February 22, 2020
If you are a consumer or patient please visit this version.
- ACTIVE INGREDIENT
Water, Dipropylene Glycol, Propylene Glycol, Glycerin, Cetyl Alcohol, Stearyl Alcohol, Glyceryl Stearate, Stearamidopropyl Dimethylamine, Behentrimonium Chloride, CetylEthylhexanoate, PPG-3 Caprylyl Ether, Steartrimonium Chloride, Panthenol, Citrus Limon (Lemon) Peel Oil, AnibaRosodora (Rosewood) Wood Oil, Caprylyl Glycol, Zinc Pyrithione, Salicylic Acid, Hydroxyethylcellulose, Citrus Reticulata (Tangerine) Peel Oil, Niacinamide, Butylene Glycol, Sodium Polynaphthalenesulfonate, 1,2-Hexanediol, Glycine, Glycine Max (Soybean) Seed Extract, VignaRadiata Seed Extract, ArchisHypogaea (Peanut) Fruit Extract, PisumSativum (Pea) Seed Extract, CanavaliaGladiata Extract, PhaseolusAngularis Seed Extract, SesamumIndicum (Sesame) Seed Extract, VacciniumAngustifolium (Blueberry) Fruit Extract, Salvia Hispanica Seed Extract, Nigella Sativa Seed Extract, RubusFruticosus (Blackberry) Fruit Extract, RibesNigrum (Black Currant) Fruit Extract, Oryza Sativa (Rice) Extract, Serine, Glutamic Acid, Aspartic Acid, Leucine, Alanine, Lysine, Arginine, Tyrosine, Phenylalanine, Valine, Threonine, Proline, Isoleucine, OenotheraBiennis (Evening Primrose) Flower Extract, UlmusDavidiana Root Extract, PinusPalustris Leaf Extract, PuerariaLobata Root Extract, Histidine, Methionine, Cysteine, Ethylhexylglycerin, Hydrolyzed Corn Protein, Hydrolyzed Wheat Protein, Hydrolyzed Soy Protein, Acacia Senegal Gum, Sodium Polynaphthalenesulfonate, Peat water, Citric Acid, Hydroxypropyl Methylcellulose, Potassium Sorbate
1. If skin develops abnormal symptoms or side effects such as red spots, swelling, and itching while or after using the product, or if the application area develops the symptoms above after exposure to direct sunlight, consult your dermatologist. 2. Do not apply on areas with open wounds. 3. Storage & Handling (1). Keep out of reach of children. (2) Keep away from direct sunlight. 4. If the product gets into eyes, rinse immediately with water 5. If you do not rinse thoroughly with water after use, it may cause hair loss or discoloration.
- KEEP OUT OF REACH OF CHILDREN
- INDICATIONS & USAGE
- PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
pyrithione zinc, dexpanthenol, niacinamide, biotin liquid
Product Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:73540-003 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 0.2 g in 100 mL PYRITHIONE ZINC (UNII: R953O2RHZ5) (PYRITHIONE ZINC - UNII:R953O2RHZ5) PYRITHIONE ZINC 0.6 g in 100 mL DEXPANTHENOL (UNII: 1O6C93RI7Z) (DEXPANTHENOL - UNII:1O6C93RI7Z) DEXPANTHENOL 0.5 g in 100 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:73540-003-01 200 mL in 1 TUBE; Type 0: Not a Combination Product 02/22/2020 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 02/22/2020 Labeler - BOBSNU CO., LTD. (689604898) Registrant - BOBSNU CO., LTD. (689604898) Establishment Name Address ID/FEI Business Operations BOBSNU CO., LTD. 689604898 manufacture(73540-003)